News Related News

Synthetic Biology and Immunotherapy to Bring More Effective Cell Therapies for Cancer

For years, the foundations of cancer treatment were chemotherapy, surgery, and radiation therapy. But over the past several years, progress with therapies that collect and use a patient’s own immune cells to attack tumors (in other words, immunotherapy) have greatly [...]

By | September 22nd, 2017|BioPharma & Healthcare, News, Therapeutics|

Meet Laura Adam, an Expert in Design Automation in Synthetic Biology

This week we interviewed Laura Adam, who will be speaking in the Computation and Synthetic Biology session (Sponsored by Amazon Web Services) at SynBioBeta SF 2017. She is an expert in the field of synthetic biology design automation and has [...]

By | September 22nd, 2017|CAD Tools, Industry Providers, News|

Ecovative Design Collaborating with Danielle Trofe Design to Launch GROW – A Grow-It-Yourself Lamp Made with Mushroom®Materials

Troy, NY and Brooklyn, NY – Creative consumers committed to the environment will soon have the opportunity to brighten their home or office with a fully grown lampshade made of sustainable materials – a lamp they can literally grow themselves.  Ecovative Design, [...]

By | September 21st, 2017|Biomaterials, Consumer Products & Manufacturing, News, Press Releases|

Benchling Announces Groundbreaking Workflow & Results Management Solution to Organize, Optimize, and Measure Biologics R&D

User-Configurable Software Increases R&D Throughput, Gives Real-Time View of Biologics Pipeline Progress SAN FRANCISCO, Sept. 20, 2017 /PRNewswire/ -- Benchling, the next-generation biologics R&D software company, today announced the release of its Workflow & Results Management system, a new class of informatics [...]

By | September 21st, 2017|CAD Tools, Industry Providers, News, Press Releases|

Oxitec to Build State-of-the-Art Mosquito Egg Production Unit

UK Prime Minister Theresa May Announces UK facility with Capacity to Generate One Billion Friendly™ Aedes Mosquito Eggs per Week OXFORD, UK September, 19, 2017 – Oxitec Ltd, a wholly owned subsidiary of Intrexon Corporation (NYSE: XON), today announced plans to [...]

By | September 21st, 2017|BioPharma & Healthcare, Disease Prevention, News, Press Releases|

Molecular Devices and Cytena Partner to Launch the CloneSelect Single-Cell Printer

Announcing the Single-Cell Printer for documented isolation of cells in clonal cell line development Sunnyvale, Calif. – September 19, 2017 – Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced a partnership with Cytena GmbH to [...]